Top Healthcare Stocks
Healthcare stocks were mixed in afternoon trade with the NYSE
Healthcare Sector Index falling about 0.4% and shares of healthcare
companies in the S&P 500 rising about 0.1% as a group.
In company news, Achillion Pharmaceuticals (
) was higher Friday after saying patients treated with its ACH-3102
drug candidate for hepatitis C showed no signs of the virus after
four weeks during Phase II testing.
According to the company, all 12 patients taking the drug when
combined with Gilead Sciences (
) Sovaldi Hep C treatment showed no detectable traces of the virus
after four weeks. ACHN now plans to begin trials with 12 additional
patients for six weeks with a once-daily dose of the two drugs.
ACHN shares were ahead nearly 10% at $9.25 apiece this
afternoon, earlier climbing to a new 52-week high of $10.20 a
share. GILD also was higher today, rising almost 3% to $99.10 a
In other sector news,
(+) CRMD, FDA accepts Phase III study protocol of Neutrolin drug
candidate in hemodialysis patients with a central venous catheter.
Also announces strategic pact with Wonik Corp. to sell Neutrolin in
South Korea after expected regulatory approval.
(-) CLRB, Prices $12.5 mln public offering of 3.33 mln shares at
$3.75 apiece, as well warrants to buy additional 3.33 mln shares at
$4.68 each. Issues 1.11 mln shares and warrants in exchange of
cancelling $4 mln of convertible debentures.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.